Ginkgo Bioworks (NYSE: DNA) is having a strong showing today. Specifically, the synthetic biology company's shares were up by 10.1% on heavy volume as of 9:57 a.m. ET Wednesday morning. Ahead of the opening bell, Ginkgo Bioworks announced an RNA-based drug development collaboration with biopharma heavyweight Pfizer (NYSE: PFE).
On Wednesday morning, NextEra Energy Partners (NYSE: NEP) was among the biggest decliners, while Ginkgo Bioworks (NYSE: DNA) got a nice boost. Smart investors are noticing these two companies and want to know what's justifying the moves. Here's your opportunity to be in the know and learn more about NextEra and Ginkgo.
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.